113 related articles for article (PubMed ID: 10866141)
21. No-mimetic furoxans: arylsulphonylfuroxans and related compounds.
Ferioli R; Fazzini A; Folco GC; Fruttero R; Calvino R; Gasco A; Bongrani S; Civelli M
Pharmacol Res; 1993; 28(3):203-12. PubMed ID: 8108310
[TBL] [Abstract][Full Text] [Related]
22. The furoxan system as a useful tool for balancing "hybrids" with mixed alpha 1-antagonist and NO-like vasodilator activities.
Fruttero R; Boschi D; Di Stilo A; Gasco A
J Med Chem; 1995 Dec; 38(25):4944-9. PubMed ID: 8523408
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of novel senkyunolide analogues as neuroprotective agents.
Fang Y; Wang R; Wang Q; Sun Y; Xie S; Yang Z; Li M; Jin Y; Yang S
Bioorg Med Chem Lett; 2018 Feb; 28(4):668-672. PubMed ID: 29370975
[TBL] [Abstract][Full Text] [Related]
24. CHF 2206, a new potent vasodilating and antiaggregating drug as potential nitric oxide donor.
Civelli M; Caruso P; Giossi M; Bergamaschi M; Razzetti R; Bongrani S; Gasco A
Eur J Pharmacol; 1994 Apr; 255(1-3):17-24. PubMed ID: 7517880
[TBL] [Abstract][Full Text] [Related]
25. A new furoxan NO-donor rabeprazole derivative and related compounds.
Sorba G; Galli U; Cena C; Fruttero R; Gasco A; Morini G; Adami M; Coruzzi G; Brenciaglia MI; Dubini F
Chembiochem; 2003 Sep; 4(9):899-903. PubMed ID: 12964168
[No Abstract] [Full Text] [Related]
26. Synthesis and vasodilating properties of N-alkylamide derivatives of 4-amino-3-furoxancarboxylic acid and related azo derivatives.
Ovchinnikov IV; Kulikov AS; Makhova NN; Tosco P; Di Stilo A; Fruttero R; Gasco A
Farmaco; 2003 Sep; 58(9):677-81. PubMed ID: 13679160
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets.
Turnbull CM; Cena C; Fruttero R; Gasco A; Rossi AG; Megson IL
Br J Pharmacol; 2006 Jun; 148(4):517-26. PubMed ID: 16702997
[TBL] [Abstract][Full Text] [Related]
28. Novel Structural Hybrids on the Base of Benzofuroxans and Furoxans. Mini-Review.
Chugunova EA; Burilov AR
Curr Top Med Chem; 2017; 17(9):986-1005. PubMed ID: 27697059
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antimalarial activities of some furoxan sulfones and related furazans.
Galli U; Lazzarato L; Bertinaria M; Sorba G; Gasco A; Parapini S; Taramelli D
Eur J Med Chem; 2005 Dec; 40(12):1335-40. PubMed ID: 15979766
[TBL] [Abstract][Full Text] [Related]
30. Role of endothelial carbon monoxide in attenuated vasoreactivity following chronic hypoxia.
Caudill TK; Resta TC; Kanagy NL; Walker BR
Am J Physiol; 1998 Oct; 275(4):R1025-30. PubMed ID: 9756530
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and pharmacological evaluation of novel NO-releasing benzimidazole hybrids as potential antihypertensive candidate.
Zhang Y; Xu J; Li Y; Yao H; Wu X
Chem Biol Drug Des; 2015 May; 85(5):541-8. PubMed ID: 25283264
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, antiplatelet and antithrombotic activities of resveratrol derivatives with NO-donor properties.
Dutra LA; Guanaes JFO; Johmann N; Lopes Pires ME; Chin CM; Marcondes S; Dos Santos JL
Bioorg Med Chem Lett; 2017 Jun; 27(11):2450-2453. PubMed ID: 28400236
[TBL] [Abstract][Full Text] [Related]
33. Searching for balanced hybrid NO-donor 1,4-dihydropyridines with basic properties.
Boschi D; Caron G; Visentin S; Di Stilo A; Rolando B; Fruttero R; Gasco A
Pharm Res; 2001 Jul; 18(7):987-91. PubMed ID: 11496959
[TBL] [Abstract][Full Text] [Related]
34. [Synthesis and vascular relaxing activity of arecoline derivatives coupled with nitric oxide donors].
Huang ST; Huang WL; Zhang HB
Yao Xue Xue Bao; 2006 Jan; 41(1):71-5. PubMed ID: 16683531
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity.
Massarico Serafim RA; Gonçalves JE; de Souza FP; de Melo Loureiro AP; Storpirtis S; Krogh R; Andricopulo AD; Dias LC; Ferreira EI
Eur J Med Chem; 2014 Jul; 82():418-25. PubMed ID: 24929292
[TBL] [Abstract][Full Text] [Related]
36. Effects of nitric oxide donor antioxidants containing the phenol vitamin E substructure and a furoxan moiety on ischemia/reperfusion injury.
Di Stilo A; Chegaev K; Lazzarato L; Fruttero R; Gasco A; Rastaldo R; Cappello S
Arzneimittelforschung; 2009; 59(3):111-6. PubMed ID: 19402340
[TBL] [Abstract][Full Text] [Related]
37. Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilatation of rat and rabbit aorta.
Weir CJ; Gibson IF; Martin W
Br J Pharmacol; 1991 Jan; 102(1):162-6. PubMed ID: 1646055
[TBL] [Abstract][Full Text] [Related]
38. Phenylsulfonylfuroxan NO-donor phenols: Synthesis and multifunctional activities evaluation.
Xie Y; Yang Y; Li S; Xu Y; Lu W; Chen Z; Yang G; Li Y; Cao Y; Bian X
Bioorg Med Chem; 2017 Aug; 25(16):4407-4413. PubMed ID: 28651914
[TBL] [Abstract][Full Text] [Related]
39. Effects of nesfatin-1 on atrial contractility and thoracic aorta reactivity in male rats.
Barutcigil A; Tasatargil A
Clin Exp Hypertens; 2018; 40(5):414-420. PubMed ID: 29027818
[TBL] [Abstract][Full Text] [Related]
40. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
